Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 303

Results For "ASH"

3656 News Found

Bayer posts higher sales, profit in first quarter
News | May 11, 2022

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1


Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY
News | May 10, 2022

Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY

The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt


U.S. Centers for Disease Control and Prevention selects Biobot Analytics to expand national wastewater monitoring
Biotech | May 10, 2022

U.S. Centers for Disease Control and Prevention selects Biobot Analytics to expand national wastewater monitoring

NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.


Roche extends commitment to the World Federation of Hemophilia Humanitarian Aid Program
News | May 10, 2022

Roche extends commitment to the World Federation of Hemophilia Humanitarian Aid Program

The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment


CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine
Biotech | May 10, 2022

CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine

CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium


Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Biotech | May 10, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need


SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
Biotech | May 09, 2022

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer


Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
News | May 09, 2022

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA

Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets


Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
Biotech | May 09, 2022

Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)


Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds
Hospitals | May 09, 2022

Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds

The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India